Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nanog homeobox pseudogene 5 (NANOGP5)
- Target
- NANOGP5
- Molecular classification
- Pseudogene, Homeobox gene family member, Processed pseudogene
01
Overview
Nanog homeobox pseudogene 5 (NANOGP5) is one of a large group of NANOG-related pseudogenes found throughout the human genome[3]. The canonical Nanog gene encodes a transcription factor essential for maintaining pluripotency in embryonic stem cells, but NANOGP5 is a processed pseudogene located on chromosome 9q31.1 and is not known to express a functional protein or participate in any biological processes. No evidence currently supports any therapeutic, biomarker, or disease role for NANOGP5; its main significance is as a marker of pseudogene diversity within the NANOG gene family[3]. If you require information about the canonical, protein-coding gene (Nanog homeobox, abbreviated NANOG), it is a transcription factor with important roles in stem cell biology and cancer, but NANOGP5 itself is only a gene relic and not a targetable molecule or functional entity[2][4][5].
- Other names
- NANOGP5Nanog pseudogene 5
02
Mechanism of action
Not applicable
03
Biological functions
None known; pseudogenes generally do not encode functional proteins
04
Disease associations
None established; the canonical NANOG gene is implicated in cancer and stem cell biology, but NANOGP5 itself has no proven disease role
05
Safety considerations
None known; pseudogenes do not produce proteins and thus have no pharmacological safety profile
06
Interacting drugs
None; pseudogenes are not drug targets unless they have acquired new functions, which is not reported for NANOGP5
07
Biomarkers
None known; no clinical evidence for use of NANOGP5 as a biomarker
Beyond the preview
Go deeper on Nanog homeobox pseudogene 5 (NANOGP5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanog homeobox pseudogene 5 (NANOGP5).